HORIZON 2020 – WORK PROGRAMME 2018-2020
General Annexes
Part 19 - Page 18 of 37
Funding rate: The EU contribution will be governed by the Rules for Participation, unless
otherwise specified in the relevant call conditions.
The eligible costs of coordination and networking activities may not exceed 50% of the total
estimated eligible costs set up in the budget of the action at the signature of the grant
agreement.
Indirect eligible costs are calculated as a flat rate of 25% of direct eligible costs, excluding
direct eligible costs for subcontracting (e.g. the price of the PPI procurement).and the costs of
resources made available by third parties (e.g. test equipment) which are not used on the
premises of the beneficiary.
Prizes
Description: Prizes are financial contributions given as rewards following the publication of
a contest. A ‘recognition prize’ is used to recognise past achievements and outstanding work
after it has been performed, whereas an ‘inducement prize’ is used to spur investment in a
given direction, by specifying a target prior to the performance of the work.
The Rules of Contest lay down the conditions for participation, the award criteria, the amount
of the prize and the arrangements for the payment of the prize to the winners after their award.
Model Rules of Contest for prizes are published on the Participant Portal
26
.
Prize amounts: The amount of the prize is specified in the contest. It is not linked to the costs
incurred by the winner.
***
Note:
1. Where duly justified the above types of actions may be implemented in the context of a framework
partnership agreement (FPA). An FPA establishes a long-term cooperation mechanism between the
Commission/Agency and the beneficiaries of grants (‘partners’). The FPA specifies the common
objectives, the procedure for awarding specific grants, rights and obligations of each party under the
specific agreements. The specific grant agreements (SGA) awarded in the context of an FPA may in
principle correspond to any of the above types of action. The Work Programme will specify the type of
action required for a given FPA, and the relevant conditions.
2. The Horizon 2020 risk finance instruments (‘financial instruments’) are described in Section 6 of
the Work Programme.
26
http://ec.europa.eu/research/participants/data/ref/h2020/prizes_manual/h2020-prizes-roc_en.pdf
HORIZON 2020 – WORK PROGRAMME 2018-2020
General Annexes
Part 19 - Page 19 of 37
E.
Specific
requirements
for
innovation
procurement
(PCP/PPI) supported by Horizon 2020 grants
This annex applies to PCPs and PPIs for which the tender preparation and/or the call for
tender implementation is supported by Horizon 2020. It applies to PCP/PPI actions (General
Annex D) and other types of actions with PCP/PPI subcontracting activities.
(i) Specific requirements for Pre-Commercial Procurement (PCP)
The following requirements apply to ensure that the definition and requirements for PCP in
the Horizon2020 Rules for Participation Regulation No 1290/2012 and the conditions for the
R&D services exemption of the EU public procurement directives
27
are respected, that the
sharing of IPR rights in PCP takes place according to market conditions and that the Treaty
principles
28
and competition rules
29
are fully respected in the PCP process:
Definitions
PCPs must comply with the Horizon 2020 definitions:
'Pre-commercial procurement' means procurement of R&D services involving risk-
benefit sharing under market conditions, and competitive development in phases, where
there is a clear separation between the procurement of the R&D services procured from
the deployment of commercial volumes of end-products
30
.
'Risk-benefit sharing under market conditions' refers to the approach in PCP where
procurers share with suppliers at market price the benefits and risks related to the IPRs
resulting from the R&D. 'Competitive development in phases' refers to the competitive
approach used in PCP by procurers to buy the R&D from several competing R&D
providers in parallel, to compare and identify the best value for money solutions on the
market to address the PCP challenge. To reduce the investment risk for the procurer,
reward the most competitive solutions and facilitate the participation of smaller innovative
companies, the R&D is also split in phases (solution design, prototyping, original
development and validation / testing of the first products), with the number of competing
R&D providers being reduced after each phase subsequent to intermediate evaluations.
'Separation from the deployment of commercial volumes of end-products' refers to the
complementarity of PCP, which focuses on the R&D phase before commercialisation, and
PPI, which does not focus on R&D but on the commercialisation/diffusion of solutions.
Procurers can but are not obliged to procure at market price R&D results from a PCP.
Eligible activities:
27
Article 16f of Directive 2004/18/EC, Article. 24e of Directive 2004/17/EC (and the EU legislation replacing
those, i.e.Article 14 of Directive 2014/24/EU and Article 32 of Directive 2014/25/EU), Article 13(f)(j) of
Directive 2009/81/EC.
28
In particular the fundamental Treaty principles on the free movement of goods and workers, the freedom to
provide services, the freedom of establishment and the free movement of capital, as well as the principles
deriving there from, such as the principles of non-discrimination, transparency and equal treatment
29
See in particular Article 2.3 of the 2014 R&D&I State aid framework
30
See Horizon 2020 Rules for Participation Regulation No 1290/2013 and PCP Communication
COM/2007/799 and associated SEC(1668)2007.